Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,869,840
  • Shares Outstanding, K 173,448
  • Annual Sales, $ 8,254 M
  • Annual Income, $ 478,000 K
  • EBIT $ 2,192 M
  • EBITDA $ 2,747 M
  • 60-Month Beta 0.35
  • Price/Sales 1.55
  • Price/Cash Flow 7.47
  • Price/Book 2.58

Options Overview Details

View History
  • Implied Volatility 32.22% (-6.98%)
  • Historical Volatility 31.15%
  • IV Percentile 53%
  • IV Rank 27.70%
  • IV High 62.22% on 04/10/25
  • IV Low 20.73% on 12/26/25
  • Expected Move (DTE 19) 4.28 (5.77%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 275
  • Volume Avg (30-Day) 320
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 7,656
  • Open Int (30-Day) 7,316
  • Expected Range 69.92 to 78.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.41
  • Number of Estimates 5
  • High Estimate 1.54
  • Low Estimate 1.34
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +5.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.49 +3.79%
on 02/23/26
82.00 -9.51%
on 02/12/26
-3.41 (-4.39%)
since 01/27/26
3-Month
71.49 +3.79%
on 02/23/26
88.20 -15.87%
on 12/02/25
-11.07 (-12.98%)
since 11/26/25
52-Week
60.70 +22.24%
on 04/09/25
88.20 -15.87%
on 12/02/25
-9.24 (-11.07%)
since 02/27/25

Most Recent Stories

More News
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

SOLV : 74.20 (-3.56%)
GH : 93.90 (-4.15%)
ALHC : 19.22 (-5.88%)
ANIP : 73.90 (-4.21%)
CLOV : 2.09 (-2.79%)
Solventum’s (NYSE:SOLV) Q4 CY2025 Sales Top Estimates

Solventum’s (NYSE:SOLV) Q4 CY2025 Sales Top Estimates

SOLV : 74.20 (-3.56%)
Solventum: Q4 Earnings Snapshot

Solventum: Q4 Earnings Snapshot

SOLV : 74.20 (-3.56%)
Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance

ST. PAUL, Minn. , Feb. 26, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025.

SOLV : 74.20 (-3.56%)
What To Expect From Solventum’s (SOLV) Q4 Earnings

What To Expect From Solventum’s (SOLV) Q4 Earnings

SOLV : 74.20 (-3.56%)
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

SOLV : 74.20 (-3.56%)
VRTX : 496.83 (+3.48%)
VMC : 310.00 (+0.33%)
3 Profitable Stocks Walking a Fine Line

3 Profitable Stocks Walking a Fine Line

SOLV : 74.20 (-3.56%)
ITW : 290.63 (+0.12%)
ADUS : 103.53 (-0.47%)
Solventum Stock: Is Wall Street Bullish or Bearish?

Solventum has lagged behind the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.

SOLV : 74.20 (-3.56%)
XLV : 160.20 (+1.77%)
$SPX : 6,878.88 (-0.43%)
3 Value Stocks We Keep Off Our Radar

3 Value Stocks We Keep Off Our Radar

SOLV : 74.20 (-3.56%)
ROCK : 45.48 (-7.24%)
RAMP : 27.17 (-0.33%)
Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026

ST. PAUL, Minn. , Feb. 3, 2026 /PRNewswire/ -- Solventum  (NYSE: SOLV) will release its fourth quarter fiscal 2025 financial results on Thursday, Feb. 26, 2026, after the U.S. financial markets...

SOLV : 74.20 (-3.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

See More

Key Turning Points

3rd Resistance Point 81.95
2nd Resistance Point 79.92
1st Resistance Point 77.06
Last Price 74.20
1st Support Level 72.17
2nd Support Level 70.14
3rd Support Level 67.28

See More

52-Week High 88.20
Fibonacci 61.8% 77.69
Fibonacci 50% 74.45
Last Price 74.20
Fibonacci 38.2% 71.20
52-Week Low 60.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar